stainwei.cnAbout company
Suzhou Sitanwei Biotechnology Co., Ltd .was established in May 2007 in Suzhou Biomedical Industrial Park (Suzhou-bioBAY) with world-class software and hardware facilities . The company's aim is to use biomedical theory as the basis for recombinant genes. Based on cell culture and protein engineering technology, they are committed to the research and development of new genetically engineered monoclonal antibodies with global intellectual property rights. The company has received a new venture, Suzhou Tong Xiang venture, Oriental Wealth, with the China Hi-Tech and many other organizations and individuals to invest , in 2008 by the Suzhou Municipal Science and Technology Bureau issued a "domestic R & D institutions," the title , the company several major The founders were awarded the Ph.D. in molecular oncology and immunology at Cornell University School of Medicine, New York University School of Medicine.
